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Abstract
Background: Despite the presence of papillary structures and papillary tumors in humans, the mechanism of papillae
formation is unknown. We describe herein a novel role for Niemann-Pick disease type 2C (NPC2) protein, a cholesterol
binding protein in the lysosome, in papillae formation.
Methodology/Principal Finding: We examined NPC2 protein expression in surgical samples of papillary tissues by
immunohistochemical stain, and all papillary tissues expressed NPC2 protein in the epithelium. To examine our hypothesis
of NPC2 protein-mediated papillae formation, we carried out xenograft experiments using wild H460 cells (large cell lung
carcinoma cell line) that constitutively expressed abundant NPC2 protein and NPC2 protein-depleted H460 cells by NPC2
shRNA. The xenografts of wild H460 cells and empty shRNA vector cells showed distinct papillae formation, whereas NPC2
protein-depleted H460 cells displayed markedly reduced or no papillae. Since all papillary tissues have open spaces we
examined whether NPC2 protein might also contribute to the creation of open spaces. The TUNEL assay in the xenografts of
wild and empty shRNA vector H460 cells showed massive cell death, and NPC2 protein-depleted cells displayed minimal cell
death. Measurement of caspase 3/7 activities in cultured H460 cells supported NPC2 protein-mediated apoptotic cell death.
The presence of excess NPC2 protein, however, did not always produce papillae as seen in the xenografts of CHO cells that
were stably transfected with NPC2.
Conclusions/Significance: The NPC2 protein of certain cells forms papillae coupled with apoptosis that creates open space.
This protein may have future applications to modulate papillae formation and papillary growth in tumor tissues.
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Introduction
In humans, ovarian fimbria, choroid plexus of the brain, villi of
the intestine, papillary cancer and papilloma are examples of
papillary structure. Papillary structure consists of a fibrovascular
core covered by epithelium creating nipple-like projections, called
fronds. One unique feature of all papillary tissues is the presence of
open spaces. There has been no report describing the mechanism
of how papillae and open spaces are formed. We previously
reported unique upregulation of human epididymal protein-1 (HE-1)i n
papillary thyroid carcinoma by two-dimensional cDNA electro-
phoresis, an unbiased gene screening [1]. This gene was later
named as Niemann-Pick disease type C2 (NPC2) because mutation of
this gene causes Niemann-Pick disease type 2C, a fatal cholesterol
storage disorder of the lysosome [2,3]. Our previous study
suggested that the NPC2 could be a specific protein for human
papillary structures [1]. In this study, all papillary tissues uniformly
expressed NPC2 protein in the epithelium. Then, we hypothesized
that the NPC2 protein could be involved in papillae formation. To
examine this hypothesis, we carried out xenograft experiments
using NPC2 protein-rich and-depleted H460 cells. Our present
study revealed the requirement of NPC2 protein for papillary
structure formation in certain cells. We describe here new
functions of the NPC2 protein—papillae formation and creation
of open spaces by apoptosis.
Results
Expression of NPC2 protein in papillary tissues
All papillary tissues examined so far showed cytoplasmic NPC2
protein in the epithelium as representative samples of normal
papillae, papilloma and papillary cancer are shown in Figure 1. In
addition, choroid plexus of the brain, colon polyps, and papillary
carcinomas of breast expressed NPC2 protein (not shown here).
Thus, NPC2 protein is associated with all papillary structures; this
raised the possibility that NPC2 protein might contribute to
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protein-rich and-depleted H460 cells.
Characterization of wild H460 cells, empty vector and
NPC2-shRNA containing H460 cells
Wild H460 cells and empty shRNA vector H460 cells showed the
same cell morphology; cells grew attaching each other. H460 cells
containing NPC2-shRNA grew as separate and individual cells
(Figure 2A). Cell proliferation activity in NPC2-shRNA containing
cells was less than 50% of that of empty vector cells after the 3
rd
day of culture (Figure 2B). Immunohistochemical stain showed
abundant NPC2 protein in wild H460 cells and empty vector cells,
whereas NPC2-shRNA-containing H460 cells had markedly
reduced NPC2 protein expression (Figure 3).
Papillae formation in xenografts
We injected the three types of H460 cells (wild cells, empty
vector cells, and NPC2-shRNA-containing cells) into nude mice and
examined xenografts for papillae formation. The xenografts of
wild H460 and empty vector cells showed distinct papillae
formation, whereas NPC2-depleted H460 cells failed to show
papilla (Figure 4A). The fibrovascular core covered by epithelium
was clearly seen in the enlarged papilla. Immunohistochemistry
showed localization of NPC2 protein in the entire epithelium of
papillae, and little NPC2 protein was seen in NPC2-depleted cells
as expected (Figure 4B).
Requirement of apoptosis to form papillary shape
Papillary structures require open spaces between papillary
fronds (Figure 1). We speculated that apoptosis might be
responsible for creating these open spaces. The TUNEL assay
from the xenograft of wild H460 cells showed massive cell death
due to DNA fragmentation, whereas the xenograft of NPC2
protein-depleted H4607 cells had minimal cell death (Figure 5).
Interestingly, the transition from epithelial cells to apoptotic cells
was clearly seen in the outer border of epithelium (middle panel of
Figure 5). To validate NPC2 protein-mediated apoptotic cell
death, we measured caspase 3/7 activities from cultured H460
cells (empty vector cells and NPC2-shRNA containing cells); both
cells were cultured under the identical conditions in the presence
of hygromycin B. As shown in Table 1, caspase 3/7 activity in
NPC2 protein-depleted cells was 13% of that of empty vector cells.
Figure 1. NPC2 protein expression in human papillary tissues. Immunohistochemical stain showed the presence of cytoplasmic NPC2 protein
(brown color) in surgical samples of human papillary tissues. All papillary tissues have open spaces outside of papillary projections. The numbers
indicate the degree of the magnification.
doi:10.1371/journal.pone.0015777.g001
Figure 2. Characterization of three types of cultured H460
cells. Cell morphology: Wild and empty vector cells showed the same
cell morphology, whereas cells containing NPC2-shRNA displayed clearly
separated individual cells. Cell proliferation activity in NPC2-rich and-
depleted H460 cells: Cells (1000 cells/well) were plated into a 96-well
plate. Cell proliferation activity on each day was measured by
incubating cells with the reagents for 2 hours in a CO2 incubator.
The results are mean 6 SD of quadruplicate samples of one of the three
experiments. *p,0.01 when compared with the empty vector cells.
doi:10.1371/journal.pone.0015777.g002
Papillae Formation
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caspase 3/7 activity expressed as relative luminescent unit (RLU)
of 78610
4615610
4 (mean 6 SD of 3 determinations), whereas
wild CHO cells had almost no caspase activity (RLU of 0 to 66).
The presence of apoptotic cells was confirmed in surgical samples
of human papillary tissues by the TUNEL assay (Figure 6).
Papillae formation by NPC2 protein-enriched CHO cells
We examined whether NPC2 protein-mediated papillae
formation takes place regardless of cell types. Wild CHO cells
showed very little NPC2 protein, and transfected cells displayed
abundant NPC2 protein (Figure 7a, b). The xenograft of CHO
cells stably transfected with NPC2 failed to show visible papilla,
despite abundant NPC2 protein expression (Figure 7c). Thus,
excessive amount of NPC2 protein does not universally lead to
papillae formation in some cells.
Discussion
This study is focused on the mechanism of papillae formation,
an unexplored area. Surgical specimens of all papillary tissues
examined so far expressed NPC2 protein in the epithelium of
papillae without exception (Figure 1). In fact, any form of papillary
projections, such as intrafollicular papillary projection in goiter
tissues [1] and colon polyps expressed NPC2 protein. Why is
NPC2 protein present in all papillary tissues? We speculated that
NC2 protein might be involved for formation of papillae. To
demonstrate NPC2-mediated papillae formation in xenografts,
cells expressing abundant NPC2 protein and depleted NPC2
protein are required. After screening several cancer cell lines, we
found wild H460 cell line that constitutively expressed abundant
NPC2 protein (Figure 3). To deplete NPC2 in H460 cells, we
constructed shRNA for NPC2, and our selected clone showed
persistent and profound depletion of NPC2 protein (Figure 3). The
xenografts of wild H460 cells and empty shRNA vector cells
showed many papillae, whereas NPC2-depleted cells showed
markedly reduced or no papillae formation depending on the
microscopic fields examined (Figure 4). We attempted to create
different levels of NPC2 protein expression by mixing wild H460
cells and NPC2-shRNA containing H460 cells with 1:1 or 1:5 ratios
(wild cells: NPC2-shRNA treated cells). The xenografts of the mixed
cells always showed many papillae as seen in the xenograft of wild
H460 cells probably due to overwhelming growth of wild H460
cells over NPC2-shRNA containing cells. Decreased cell prolifera-
tion activity by NPC2-shRNA containing cells (Figure 2B) supports
this phenomenon. Restricted localization of NPC2 protein to the
Figure 3. NPC2 protein expression in cultured H460 cells. Immunohistochemical staining showed abundant NPC2 protein in wild and empty
vector cells and markedly reduced NPC2 protein in NPC2-shRNA-containing cells.
doi:10.1371/journal.pone.0015777.g003
Figure 4. Papillae formation in xenografts of three types of H460 cells. A: Hematoxylin-eosin stain. B: Immunohistochemical stain for NPC2
protein. Distinct papillae formation was seen in wild and empty vector cells. No papilla was seen in NPC2-shRNA containing cells (A). NPC2 protein
was localized in the epithelium of papillae (B).
doi:10.1371/journal.pone.0015777.g004
Papillae Formation
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fronds formation. One unique feature of all papillary tissues is the
presence of open spaces (Figure 1), and this could be crucial for the
growth of papillary fronds. The mechanism of creating these open
spaces has never been addressed. The TUNEL assay in the
xenografts of wild H460 cells showed massive cell death between
papillary fronds and a minimal cell death in NPC2 protein-
depleted cells (Figure 5). Apoptosis is defined by caspase-mediated
cell death [4]. Measurement of caspase 3/7 activities in cultured
H460 cells supports NPC2 protein-mediated apoptosis (Table 1).
Also, the TUNEL assay from human samples showed apoptotic
cells (Figure 6). Apoptosis in papillary tissues can be summarized
as follows. 1) Epithelial cells producing NPC2 protein can become
apoptotic. 2) Apoptosis starts from the outer border of the
epithelium. 3) Apoptosis should contribute to the formation of
open spaces in papillary structures. In addition, apoptotic activity
was seen in CHO cells transfected with NPC2 but not in wild
CHO cells. The NPC2 protein is localized in the lysosome for
cholesterol binding and transport [2,3], and the lysosome can
activate intrinsic and extrinsic pathways of apoptosis under certain
conditions [5]. Our study suggests that NPC2 protein itself can
cause apoptosis. The mechanism of triggering apoptosis by
excessive NPC2 protein has yet to be studied.
The question can be raised whether the expression of abundant
NPC2 protein alone is sufficient to form papillae regardless of cell
types. We examined this question in CHO cells that were stably
transfected with NPC2. No papilla formation was seen in the
xenografts, despite abundant NPC2 protein (Figure 7C). This
finding suggests that an increase in cholesterol binding to NPC2
protein and its transport to the membrane, well known function of
NPC2, is not solely responsible for papillae formation. Similarly,
human liver highly expresses NPC2 without papillary structure [2].
Therefore, an enrichment of NPC2 protein alone does not always
produce papillae in certain cells. It is conceivable that additional
factors or proteins are required to form papillae together with the
NPC2 protein. We had an opportunity to examine NPC2
hypomorphous mouse expressing 0–4% of NPC2 protein; this
mouse was kindly provided by Dr. Peter Lobel [6]. We found
normal papillae in the choroid plexus of the brain and villi of the
intestine in this mouse. Therefore, the discrepancy of papillae
formation between xenograft experiments (tumor of NPC2
depleted cells under the skin) and live animal model (born with
NPC2 defect) exists. It is speculated that this mouse model may
have NPC2 independent mechanisms or might have developed
alternative mechanisms to form papillae. In humans, patients with
Niemann-Pick Disease type 2C represent human model of NPC2
protein depletion. However, there is no autopsy report examining
papillary tissues in this disorder.
The clinical application of NPC2 protein in papillae forming
diseases has yet to be identified. Upregulation of NPC2 in human
papillary thyroid cancer [1] and significant decrease in cell
proliferation in NPC2-depleted H460 cells (Figure 2B) suggest that
NPC2 protein may also control cell proliferation in papillary
tumors. Whether blocking NPC2 action has any therapeutic value
for papillary cancer has yet to be studied in vivo. Exogenous NPC2
protein is taken into cells via two mannose 6 phosphate receptors
that are ubiquitously present in the membrane [7] and corrected
the abnormality of cholesterol handling in fibroblasts from a
patient with NPC2 mutation [2]. Therefore, it is interesting to
examine whether addition of exogenous NPC2 protein restores
disrupted papillary structures, such as epithelial atrophy of choroid
plexus in Alzheimer disease [8].
Methods
Ethical statement
Paraffin sections of surgical samples were obtained from
Hirosaki University Hospital, Hirosaki, Japan. The ethical
committee of Hirosaki University School of Medicine exempted
this human study including obtaining the consent from patients
because paraffin section samples are 13 year-old with unidentifi-
able patients and no direct linkage of this study to the health care
management. This is in accord with the human study guidelines
established by the Ministry of Education and Science and the
Ministry of Health and Welfare in Japan.
The animal experiments proposed here were fully approved by
the GLA-VA Institutional Animal Care and Use Committee
(IACUC) with protocol number of 02004-05. All animal
experiments were carried out under the regulation of IACUC.
Cells and surgical samples
H460 cells (large cell lung cancer cell line) and CHO cells
(Chinese ovarian cells) were obtained from ATCC, Manassas,
VA., and cultured in RPMI1640 medium and F-12 medium,
Figure 5. TUNEL assay in xenografts NPC2 protein-rich and-depleted cells. Apoptotic ell death was seen between papillary structures
(brown colored areas) in wild H460 cells. The transition from epithelial cells (blue colored cells) to apoptotic cells (brown colored cells) was seen in the
outer border of epithelium (middle panel). NPC2 protein-depleted H460 cells showed only small areas of apoptotic cell death.
doi:10.1371/journal.pone.0015777.g005
Table 1. Caspase 3/7 activities in cultured H460 cells.
Cell types Caspase 3/7 activities
Empty vector cells 100%612.5%
NPC2-shRNA cells 13.5%65.8%
Caspase activity of empty vector cell is considered as 100%. The results are
mean 6 SD of three different experiments performed in duplicates. *p,0.0004.
doi:10.1371/journal.pone.0015777.t001
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antibiotic cocktail.
Preparation for NPC2 protein-rich and-depleted cells
We used wild H460 cells, since this cell line constitutively
expressed abundant NPC2 protein. We also made NPC2 protein-
rich CHO cells by stable transfection of CHO cells with NPC2. For
the NPC2 transfection experiment, we obtained the entire coding
region of human NPC2 cDNA (NM_006432) from 3 mg total RNA
of BHP 2-7 human papillary thyroid cancer cells by two-step RT-
PCR using Superscript III (Invitrogen, CA.), Expand High Fidelity
PCR System (Roche Applied Science, Indianapolis, IN), and
custom primers (Invitrogen), 59-GATGCGTTTCCTGGCAG-
CTA-39 and 59-CTGCTAACCAAGTGCTGCAT-39. We intro-
duced the amplicons into the pCR 2.1 vector (Invitrogen),
confirmed the correct sequences of the insert, and sub-cloned it
into a mammalian expression vector pcDNA3 (Invitrogen) with
HindIII and XbaI (New England Biolabs, Ipswich, MA). We
carried out transfection of CHO cells with NPC2 in pcDNA3 using
Effectene Transfection Reagents (Qiagen, Valencia, CA) and
selected clones expressing constant and abundant NPC2 protein in
the presence of geneticin. Wild CHO cells contained very little
NPC2 protein.
NPC2 knockdown experiments in H460 cells
We designed the target DNA sequences corresponding to NPC2-
shRNA using the online program (Applied Biosystems/Ambion,
Austin, TX) and ligated the target DNA to the pSilencer3.1-H1 hygro
vector (Applied Biosystems/Ambion). After confirming the correct
sequences of the insert from the amplified plasmid, we transfected
H460 cells with NPC2-shRNA or shRNA vector alone (empty vector)
using the T-20 program of the Amaxa Nucleofector II (Lonza
Group, Ltd., Boston, MA). We selected stably transfected clones
by culturing cells in the presence of 500 mg/ml hygromycin B
(Invitrogen). The silencing effect of NPC2-shRNA on NPC2 and its
protein expression was confirmed by RT-PCR and immunohis-
tochemistry staining, respectively. The most effective NPC2-shRNA
insert inhibiting NPC2 protein expression contained the following
sequences: 59GATCCGTGGTATCCAGTGATTCGTTCTCA-
AGAGAAACGAATCACTGGATACCATTTTTTGGAAA-39,
and 59AGCTTTTCCAAAAAATGGTATCCAGTGATTCGT-
TTCTCTTGAGAACGAATCACTGGATACCACG-39.
Animal experiments
We obtained female nude mice (15 g) from Charles-River
Laboratories INC, Wilmington, MA, and all animals were kept in
sterile cages. We injected 10
6 cells in 0.1 ml phosphate buffered
saline (PBS) subcutaneously to the flank region of mice. After
tumors grew to 1–1.5 cm in diameter, we sacrificed animals in a
CO2 chamber, removed tumors, and kept sliced tumor samples in
formalin for immunostaining.
Immunohistochemical staining, TUNEL assay and image
analysis
Immunohistochemical studies were performed on formalde-
hyde-fixed, paraffin-embedded tissues. Deparaffinized sliced
sections were incubated for 60 min at room temperature with
the rabbit polyclonal anti-human NPC2 antiserum (1:1000).
Polyclonal anti-human NPC2 antibody was kindly provided by
Dr. Peter Lobel, Rutgers University. Immunostaining was carried
o u tu s i n gaD a k oa u t o s t a i n e ri nc onjunction with the EnVision
TM
detection kits (Dako, Carpinteria, CA). Positive controls (human
epididymis tissue originally shown to express NPC2) and negative
controls (without antibody) were used for NPC2 immunostai-
ning. For TUNEL assay in sliced tissues, we used Apop Tag
Peroxidases In Site Apoptosis Detection kit (Millipore Co.,
Bellireca, MA). For image analysis, we used Metamorph
TM image
analysis software version 7.5 (Molecular devices, Downingtown,
PA).
Figure 7. NPC2 protein expression in CHO cells. Immunohistochemical stain of NPC2 protein in wild CHO cell (a), CHO cells stably transfected
with NPC2 (b) and xenograft of CHO cells transfected with NPC2 (c). No papilla was seen in the xenograft, despite abundant NPC2 protein expression.
doi:10.1371/journal.pone.0015777.g007
Figure 6. Presence of apoptotic cells in human papillary tissues. TUNEL assay showed the presence of apoptotic cells in representative
samples of human papillary tissues; arrows indicate examples of apoptotic cells.
doi:10.1371/journal.pone.0015777.g006
Papillae Formation
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Caspase 3/7 activities were measured from cultured cells using
Promega caspase-Glo luminescent method (Promega, Madison.
WI). We used H460 cells containing empty shRNA vector and
NPC2-shRNA. These cells were thawed on the same day and
cultured in 6-well plate in the presence of hygromycin B until 80%
confluence was achieved. Cells were washed with PBS twice and
sonicated in 1 ml PBS. An aliquot of 50 ml sonicate corresponding
to 6610
4 cells was used immediately for caspase 3/7 assay. Each
assay was run with or without 5 units Z-VAD-FMK, caspase
inhibitor (Promega), by incubating the reaction mixture for 30 min
at 37uC, and relative luminescent unit (RLU) was measured by
GloMax 20/20 luminometer (Promega). We defined caspase
activity as the RLU that was inhibited in the presence of caspase
inhibitor. Similarly, we measured caspase3/7 activities from wild
CHO cells and transfected CHO cells with NPC2.
Cell proliferation assay
We used empty vector cells and NPC2-shRNA cells by plating
1000 cells/well in a 96-well plate; they were cultured under the
identical condition in the presence of hygromycin B. Cell
proliferation was measured using a quick cell proliferation assay
kit (BioVision, Mountain View, CA) on first, third and fifth days of
cell culture. The optical density from each well was measured at
440 nm using a microplate reader (Molecular devices, Sunnyvale,
CA).
Statistical analysis
The results of caspase activity and cell proliferation assay were
analyzed by Student’s t-test based on difference of variance (F test).
The p value less than 0.05 were considered significant.
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